Holen Sie sich die Stockscreener-App
5.06
0.80%
0.04
Handel nachbörslich:
5.13
0.07
+1.38%
Schlusskurs vom Vortag:
$5.02
Offen:
$5.05
24-Stunden-Volumen:
104.29K
Relative Volume:
0.22
Marktkapitalisierung:
$8.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-4.40
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
-23.33%
1M Leistung:
+11.21%
6M Leistung:
-38.70%
1J Leistung:
-86.40%
1-Tages-Spanne:
$4.90
$5.59
1-Wochen-Bereich:
$4.90
$6.7099
52-Wochen-Spanne:
$3.80
$38.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
5.06 | 10.45M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
What dividend safety score for Acurx Pharmaceuticals Inc. stockAnalyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
Is Acurx Pharmaceuticals Inc. stock recession proof2025 Short Interest & Stock Market Timing Techniques - newser.com
How to interpret RSI for Acurx Pharmaceuticals Inc. stockMarket Trend Report & Long-Term Capital Growth Ideas - newser.com
Will Acurx Pharmaceuticals Inc. stock split attract more investorsTrade Volume Summary & Safe Capital Investment Plans - newser.com
What is the fair value of Acurx Pharmaceuticals Inc. stock nowMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain free cash flow growth2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
How resilient is Acurx Pharmaceuticals Inc. stock in market downturnsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
What risks investors should watch in Acurx Pharmaceuticals Inc. stockJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Can Acurx Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Performance Report & Weekly Sector Rotation Insights - newser.com
Can swing trading help recover from Acurx Pharmaceuticals Inc. lossesFed Meeting & Daily Growth Stock Tips - newser.com
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain market leadershipEntry Point & High Conviction Buy Zone Picks - newser.com
How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stockQuarterly Trade Report & Proven Capital Preservation Methods - newser.com
Combining price and volume data for Acurx Pharmaceuticals Inc.Portfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
Acurx Pharmaceuticals Inc Stock Analysis and ForecastEmerging Market Stocks & Low Cost Wealth Investment - earlytimes.in
Is Acurx Pharmaceuticals Inc. (3ZO) stock overpriced at current multiplesJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
How strong is Acurx Pharmaceuticals Inc. (3ZO) stock earnings growthWeekly Trend Report & Fast Gain Stock Tips - newser.com
Pattern recognition hints at Acurx Pharmaceuticals Inc. upsideGold Moves & Free Safe Capital Growth Stock Tips - newser.com
Why Acurx Pharmaceuticals Inc. stock appeals to analystsWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Will Acurx Pharmaceuticals Inc. stock outperform growth indexesMarket Trend Summary & Daily Oversold Stock Bounce Ideas - newser.com
Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Grows By 82.1% - Defense World
Multi factor analysis applied to Acurx Pharmaceuticals Inc.Recession Risk & Accurate Buy Signal Notifications - newser.com
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.
Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
Comparing Acurx Pharmaceuticals Inc. in custom built stock radarsDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Acurx Pharmaceuticals’ Ibezapolstat: Promising Preclinical and Clinical Efficacy Supports Buy Rating - TipRanks
Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans - MSN
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):